Иммунология. Том 2 - Дэвид Г.
ISBN 5-03-000497-1
Скачать (прямая ссылка):
24. Watson J., Mochizuti D. Interleukin 2: A class of lymphocyte growth factors, Immunol. Rev., 511 257—278 (1980).
25. Mizel S. Lymphokines in antibody and cytotoxic responses. In: Lymphokines 6, ed. by S. Mizel, p. XI, Academic Press, New York, 1982.
26. Rosenstreich D. L., Farrar J. J., Dougherty S. Absolute macrophage dependency of T lymphocyte activation by mitogens, J. Immunol., 116, 131—139 (1976).
27. Oppenheim J., Mizel S., Meltzer M. Comparison of lymphocyte and mononuclear phagocyte derived mitogenic «amplification» factors. In: Biology of the Lymphokines, ed. by S. Cohen, E. Pick, and J. Oppenheim, pp. 291—310, Academic Press, New York, 1979.
28. Smith K. A., Gilbride K. J., Favata M. F. Interleukin-l-promoted interleukin-2 production, Behr. Instit. Mitteil., 67, 4—11 (1980).
29. Mizel S. B. Studies on the purification and structure-function relationships of murine lymphocyte activating factor (Interleukin 1), Mol. Immunol., 17, 571—577 (1980).
30. Smith K. S., Gilbridge K. J., Favata M. F. Lymphocyte activating factor promotes T-cell grpwth factor production by cloned murine lymphoma cells, Nature, 287, 853—855 (1980).
31. Gillis S., Mizel S. B. T-cell lymphoma model for the analysis of interleukin 1-mediated T-cell activation, Proc. Natl. Acad. Sci. USA, 78, 1133—1137 (1981).
32. Maizel A. L., Mehta S. R., Hauft S., Franzini D., Lachman L. В., Ford R. J. Human T lymphocyte/monocyte interaction in response to lectin: Kinetics of entry into the S-phase, J. Immunol., 127, 1058—1064 (1981).
33. Mizel S. B., Mizel D. Purification to apparent homogeneity of murine interleukin 1, J. Immunol., 126, 834—837 (1981).
34. Gillis S., Crabtree G. R., Smith K. A. Glucocorticoid-induced inhibition of T-cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation, J. Immunol., 123 1624—1631 (1979).
35. Gillis S., Crabtree C. R., Smith K. A. Glucocorticoid-induced inhibition of T-cell growth factor production. II. The effect on the in vitro generation of cytolytic T-cells, J. Immunol., 123, 1632—1637 (1979).
36. Gillis S., Henney C. S. The biochemical and biological characterization of lymphocyte regulatory molecules, J. Immunol., 126, 1978—1984 (1981).
37. Gillis S., Gillis A. E., Henney C. S. Monoclonal antibody directed against interleukin 2, J. Exp. Med., 154, 983—988 (1981).
38. Stadler В. М., Berenstein E. H., Siraganian R. P., Oppenheim J. J. Monoclonal antibody against human interleukin 2 (IL-2), J. Immunol., 128, 1620—1624 (1981).
39. Robb R. J., Munck A., Smith K. A. T-cell growth factor receptors: Quantitation, specificity and biological relevance, J. Exp. Med., 154, 1455—1474 (1981).
40. Smith K. A. T-cell growth factor, a lymphocytotrophic hormone. In: Proceedings of the 55th Nobel Symposium, Genetics of the Immune Response, pp. 151—185, Plenum, New York, 1983.
41. Farrar J. J., Fuller-Farrar JSimon P. L., Hilfiker M. L., Stadler В. M., Farrar W. L. Thymoma production of T-cell growth factor, J. Immunol., 125, 2555—2558 (1980).
42. Gillis S., Watson J. Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin-2-producing human leukemia T-cell line, J. Exp. Med., 152, 1709—1719 (1980).
43. Gillis S., Smith K. A., Watson J. D. Biochemical and biological characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines, J. Immunol., 124, 1954—1962 (1980).
44. Robb R. J., Smith K. A. Heterogeneity of human T-cell growth factor due to glycosylation, Mol. Immunol., 18, 1087—1094 (1981).
45. Leonard W. J., Depper J. М., Uchiyama Т., Smith K. A., Waldmann T. A., Greene W. C. A monoclonal antibody, anti-Tac, blocks the membrane binding and action of human T-cell growth factor, Nature, 300, 267—269 (1982).
46. Brunner К. Т., Manuel J. Cerottini J. C., Chapuis В. Quantitative assay of the lytic action of immune lymphoid cells on 51Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs, Immunology, 14, 181—196 (1968).
47. Manuel JRudolf H., Chapuis B., Brunner К. T. Studies of allograft immunity in mice, Immunology, 18, 517—535 (1970).
48. Wagner H., Feldmann M. Cell mediated immune response in vitro. I. A new in vitro system for the generation of cell-mediated cytotoxic activity, Cell. Immunol., 3, 405—420 (1972).
49. Wagner HRollinghoff М. T — T-cell interactions during in vitro cytotoxic allograft responses, J. Exp. Med., 148, 1523—1538 (1978).
50. MacDonald H. R., Cerottini J. C., Ryser J. E., Maryanski J. L., Taswell C., Widmer М. B., Brunner К. T. Quantitation and cloning of cytolytic T-lymphocytes and their precursors, Immunol. Rev., 51, 93—123 (1980).
51. Raulet D. H., Bevan M. J. A differentiation factor required for the expression of cytotoxic T-cell function, Nature, 296, 754—757 (1982).
52. Kaieda Т., Okada М., Yoshimura N., Kishimoto S., Yamamura Y., Kishimoto T. A human helper T cell clone secreting both killer helper factor(s) and T cell-replacing factor(s), J. Immunol., 129, 46—51 (1982).
